Suzanne De La Monte

Brown UniversityUnited States of America

Dr. Suzanne M. de la Monte, M.D., M.P.H. is Professor of Neuropathology, Neurology, and Neurosurgery at the Rhode Island Hospital and the Alpert Medical School of Brown University, Providence, RI. She received her undergraduate degree from Cornell University, Ithaca, N.Y., M.D. from the Weill College of Medicine at Cornell University, and masters in public health (M.P.H.) from the Blumberg School of Public Health at Johns Hopkins University, Baltimore, MD. Dr. de la Monte completed her residency in Anatomical Pathology and fellowship in Pediatric Pathology at The Johns Hopkins Hospital, and a fellowship in Neuropathology at the Massachusetts General Hospital. She received postdoctoral research training at the Massachusetts General Hospital. Currently, Dr. de la Monte directs research on the role of insulin resistance as a mediator of neurodegeneration in relation to Alzheimer’s disease, alcoholism, obesity, diabetes, and development. Her research led to the provocative concept that Alzheimer’s is “Type 3 Diabetes”.

2books edited

1chapters authored

Latest work with IntechOpen by Suzanne De La Monte

The Clinical Spectrum of Alzheimer's Disease: The Charge Toward Comprehensive Diagnostic and Therapeutic Strategies is highly informative and current. Acknowledged experts in the field critically review both standard and under-appreciated clinical, behavioral, epidemiological, genetic, and neuroimaging attributes of Alzheimer's disease. The collection covers diverse topics of interest to clinicians and researchers alike. Experienced professionals and newcomers to the field will benefit from the read. The strengths and weaknesses of current clinical, non-invasive, neuro-imaging, and biomarker diagnostic approaches are explained. The perspectives give fresh insights into the process of neurodegeneration. Readers will be enlightened by the evidence that the neural circuits damaged by neurodegeneration are much broader than conventionally taught, suggesting that Alzheimer's could be detected at earlier stages of disease by utilizing multi-pronged diagnostic approaches. This book inspires renewed hope that more effective treatments could be developed based upon the expanding list of potential therapeutic targets.

Go to the book